Table 2.
Inhibitors showing binding affinities against active sites of target proteins.
RdRp |
Mpro |
Spike glycoprotein |
||||||
---|---|---|---|---|---|---|---|---|
Sr. # | Ligand | PubChem ID | Energy score (kcal/mol) (MOE) Molecular Operating Environment | Binding Affinity (KD) Dissociation Constant (Discovery studio) | Energy score (kcal/mol) (MOE) | Binding Affinity (KD) (Discovery studio) | Energy score (kcal/mol) (MOE) | Binding Affinity (KD) (Discovery studio) |
1 | Teprotide | 443,376 | −7.25 | −9.7 | −10.95 | −12.4 | −6.95 | −10.9 |
2 | Moexipril | 91,270 | −10.27 | −13.5 | −7.55 | −7.1 | −5.93 | −7.3 |
3 | Cilazapril | 56,330 | −9.03 | −9.8 | −7.99 | −7.9 | −6.35 | −7.9 |
4 | Benazepril | 5,362,124 | −8.97 | −8.9 | −8.88 | −9.0 | −6.34 | −7.9 |
5 | Trandolapril | 5,484,727 | −6.76 | −8.7 | −8.04 | −8.4 | −6.93 | −8.0 |
6 | Quinapril | 54,892 | −7.74 | −8.5 | −8.45 | −8.7 | −6.32 | −7.7 |
7 | Lisinopril | 5,362,119 | −8.36 | −8.1 | −6.01 | −6.7 | −5.48 | −6.5 |
8 | Enalapril | 5,388,962 | −8.50 | −8.0 | −7.77 | −7.7 | −5.94 | −7.3 |
9 | Ramapril | 121,486,657 | −8.34 | −8.0 | −6.17 | −6.9 | −6.31 | −7.7 |
10 | Perindopril | 107,807 | N/A | −6.8 | −7.13 | −6.9 | −6.02 | −7.4 |
11 | Captopril | 44,093 | −5.40 | −6.5 | −6.00 | −6.2 | −5.34 | −6.5 |
12 | Allicin | 65,036 | No interaction | −4.9 | −5.90 | −4.7 | −5.21 | −4.9 |